Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 1096-1100, June 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pienta, R. J.
Right arrow Articles by Groupé, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pienta, R. J.
Right arrow Articles by Groupé, V.

Relationship of Infecting Dose to Recovery of Rauscher Murine Leukemia Virus (RMLV) in Random Bred Swiss Mice1

Roman J. Pienta2 and Vincent Groupé

Institute of Microbiology, Rutgers. The State University, New Brunswick, New Jersey 08903

Random bred Swiss mice were infected with graded decimal doses of Rauscher murine leukemia virus via the intravenous or intraperitoneal routes. Samples of spleen and plasma were then collected at various times after infection. Bioassay of these samples in recipient mice revealed a definite relationship between the amount of virus used to initiate the infection and the amount of virus recovered as measured by a spleen focus assay. Highest infective titers were obtained when the most concentrated inocula were used and the relative titers of virus in the pooled plasmas and spleens decreased as successively less concentrated inocula were used to initiate the infection. Plasma and spleen samples contained more virus when the inocula were injected intravenously than when injected intraperitoneally. In addition, virus was detectable earlier and persisted at higher levels when the initiating virus was injected intravenously rather than intraperitoneally.

1 This investigation was supported by PHS Research Grant Nos. CA-04313-05 and CA-05175 from the National Cancer Institute.

2 Present address: Department of Pathology, The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77025.

Received 12/12/66. Accepted 2/14/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.